J. Goldman & Co’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

J. Goldman & Co’s Portfolio OPTR Stock Details OPTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-65,066	Closed	-$819K	–	358
2013 Q3	$819K	Buy	+65,066	New	+$862K	0.08%	210

J. Goldman & Co's OPTR Position: Q4 2013 in Review

J. Goldman & Co sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 65,066 shares — an estimated $819K sold.

J. Goldman & Co first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $819K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

J. Goldman & Co reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
J. Goldman & Co sold 65,066 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $819K.
J. Goldman & Co first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
J. Goldman & Co's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $819K in Q3 2013.
0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.